Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug:4:100186.
doi: 10.1016/j.ijcchd.2021.100186. Epub 2021 Jun 16.

Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

Jolanda Sabatino  1   2 , Giovanni Di Salvo  1 , Giuseppe Calcaterra  3 , Pier Paolo Bassareo  4 , Lilia Oreto  5 , Ilaria Cazzoli  6 , Maria Pia Calabrò  7 , Paolo Guccione  6 , Michael A Gatzoulis  8   9 ; Congenital Heart Disease Working Group of the Italian Society of Cardiology (SIC)
Affiliations

Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

Jolanda Sabatino et al. Int J Cardiol Congenit Heart Dis. 2021 Aug.

Abstract

Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.

Keywords: ACHD; COVID-19; Risk factors; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Risk stratification schema of ACHD patients according to anatomical and physiological patterns. CAD ​= ​coronary artery disease; PAOD ​= ​peripheral arterial occlusive disease; CV ​= ​cardiovascular.
See this image and copyright information in PMC

References

    1. Cheng V.C., Lau S.K., Woo P.C., Yuen K.Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20:660–694. - PMC - PubMed
    1. Mehra M.R., Desai S.S., Kuy S., Henry T.D., Patel A.N. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382:e102. - PMC - PubMed
    1. Sabatino J., De Rosa S., Di Salvo G., Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PloS One. 2020 Aug 14;15(8) doi: 10.1371/journal.pone.0237131. - DOI - PMC - PubMed
    1. Driggin E., Maddox T.M., Ferdinand K.C., Kirkpatrick J.N., Ky B., Morris A.A., Mullen J.B., Parikh S.A., Philbin D.M., Jr., Vaduganathan M. ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2021 Apr 20;77(15):1938–1948. doi: 10.1016/j.jacc.2021.02.017. - DOI - PMC - PubMed
    1. Egidy Assenza G., Castaldi B., Flocco S., Luciani G.B., Meliota G., Rinelli G., Vairo U., Favilli S. Board of the Italian society of pediatric cardiology. COVID-19 vaccine priority access for adults and children with congenital heart disease: a statement of the Italian society of pediatric cardiology. Congenit Heart Dis. 2021 doi: 10.32604/CHD.2021.016713. - DOI